Export 3 results:
Author [ Title(Asc)] Type Year
Filters: Author is Sparenborg, Steve  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
R. Lindblad, Campanella, M., Styers, D., Kothari, P., Sparenborg, S., and Rosa, C., “Strategies for safety reporting in substance abuse trials.”, Am J Drug Alcohol Abuse, vol. 37, no. 5, pp. 440-5, 2011.
B
W. Ling, Hillhouse, M. P., Saxon, A. J., Mooney, L. J., Thomas, C. M., Ang, A., Matthews, A. G., Hasson, A., Annon, J., Sparenborg, S., Liu, D. S., McCormack, J., Church, S., Swafford, W., Drexler, K., Schuman, C., Ross, S., Wiest, K., P Korthuis, T., Lawson, W., Brigham, G. S., Knox, P. C., Dawes, M., and Rotrosen, J., “Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: the Cocaine Use Reduction with Buprenorphine (CURB) study.”, Addiction, vol. 111, no. 8, pp. 1416-27, 2016.
A
E. A. McClure, Sonne, S. C., Winhusen, T., Carroll, K. M., Ghitza, U. E., McRae-Clark, A. L., Matthews, A. G., Sharma, G., Van Veldhuisen, P., Vandrey, R. G., Levin, F. R., Weiss, R. D., Lindblad, R., Allen, C., Mooney, L. J., Haynes, L., Brigham, G. S., Sparenborg, S., Hasson, A. L., and Gray, K. M., “Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network.”, Contemp Clin Trials, vol. 39, no. 2, pp. 211-23, 2014.